Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instituto de Microcirugía Ocular (IMO) is a private, specialized ophthalmology provider based in Barcelona and operating as part of IMO Grupo Miranza. The organization focuses on diagnosis, medical and surgical treatment, and long-term management of eye diseases, with particular strength in complex and combined ophthalmic surgery. IMO offers subspecialty care across retina, cornea, cataract, glaucoma, pediatric ophthalmology, oculoplastics, refractive surgery, ocular genetics, and dry eye. The group also maintains in-house molecular biology and genetics capabilities in Barcelona and participates in ophthalmology research, including clinical studies and emerging therapies for ocular diseases. It operates established clinical sites in Barcelona, Madrid, Manresa, and Andorra.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instituto de Microcirugía Ocular.